Skip to content

Early UVFP Management Based on Neurological Evidences (UVFP = Unilateral Vocal Fold Paralysis)

Early UVFP Management Based on Neurological Evidences UVFP = Unilateral Vocal Fold Paralysis

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03906877
Acronym
IONS-UVFP
Enrollment
6
Registered
2019-04-08
Start date
2019-11-15
Completion date
2023-09-30
Last updated
2023-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Unilateral Vocal Cord Paralysis

Brief summary

The aim of this study is to understand how early intervention could impact reinnervation of the recurrent laryngeal nerve (which innervates the vocal cord), recovery of mobility of the paralyzed vocal cord and / or vocal recovery in the case of unilateral vocal fold paralysis. To achieve this goal we must therefore carry out a complete outcomes assessment of different intervention methods (voice therapy and injection laryngoplasty), which are offered to UVFP (unilateral vocal fold paralysis) patients in the early stage (\< 3 months). Their respective impacts on the central and peripheral nervous system and on the voice quality will be assessed, taking into account factors related to the severity of the paralysis.

Interventions

PROCEDUREAcid hyaluronic injection laryngoplasty

Hyaluronic acid is injected into the paralyzed vocal fold

BEHAVIORALVoice therapy

15 sessions of thirty minutes of voice therapy, twice a week, and home practice. This voice management will be specific to unilateral vocal fold paralysis and will focus on three objectives: reinforcement of the vocal muscle, glottal closure and glottal opening. These three objectives will be worked through different vocal exercises (on voiced phonemes) and breathing exercises

OTHERSham of injection

Injection of physiological saline under the skin of the neck (sham of injection).

OTHERSham of voice therapy

15 sessions of thirty minutes of voice therapy, twice a week, and home practice. This voice management will not be specific to UVFP but may allow patients to improve their vocal gesture.

Sponsors

Cliniques universitaires Saint-Luc- Université Catholique de Louvain
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Subject)

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

\- Unilateral paralysis in abduction of the vocal cords may be included in the study.

Exclusion criteria

* Wear a pacemaker or other implanted devices (prostheses ...). * Wear metal clips, metal in the head, or an adjustable brain drain. * Wear non-removable dental appliances (except fillings). * Wear cardiac valve prostheses. * Have worked the metals. * Have a tattoo containing metal particles. * Have implanted jewelry (e.g., piercing). * Being prone to epileptic seizures. * Take medications that alter cortical excitability. * Have had a brain surgery. * Suffer from intracranial hypertension. * Be pregnant or breastfeeding recently. * Present allergies that are incompatible with the experimental protocol. * Have an abnormal hearing loss in view of their age, identified with tonal and / or vocal audiometry.

Design outcomes

Primary

MeasureTime frameDescription
Laryngeal recurrent nerve reinnervation9 to 12 months after paralysisDefined through qualitative laryngeal electromyography
Recovery of the vocal fold mobility9 to 12 months after paralysisVideostroboscopy examination to analyse vocal folds movements in three dimensions
Voice recovery9 to 12 months after paralysisMultidimensional voice assessment (based on anamnestic interview, Maximum Phonation Time in sec, Mean Air Flow in ml/sec, Mean subglottic pressure in cmH2O, Jitter in %, Shimmer in %, Noise-to-harmonic ratio, phonetogram, smoothed cepstral peak prominence in %, Voice Handicap Index - VHI-30 (\*total\* : 0-120, higher value = worse outcome), Medical Outcomes Study 36-item Short Form Healthy Survey (\*8 subscales\* : 0-100, higher value = better outcome, Eating Assessment Tool-10 (\*total\*: 0-40, higher value = worse outcome), GRBAS-I (\*6 subscales\* : 0-3, higher value = worse outcome), Acoustic Voice Quality Index, Dysphonia Severity Index (DSI = 0.13 x MPT + 0.0053 x F(0)-High - 0.26 x I-Low - 1.18 x Jitter (%) + 12.4),Tonal and vocal audiometries in dB)
Changes in the neuronal pathways involved in the processing of the proprioceptive and auditory inputs9 to 12 months after paralysisFunctional magnetic resonance imaging examination (tomodensitometry and connectivity)
Central auditory processesWithin 3 months after paralysisAuditory perception tasks performed using an audio headset

Countries

Belgium

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026